APA

Bughani U., Saha A., Kuriakose A., Nair R., Sadashivarao R. B., Venkataraman R., Patel S., Deshchougule A. T., S S. K., Montero E., Pai H. V., Palanivelu D. V., Melarkode R. & Nair P. (20171006). T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab. : PloS one.

Chicago

Bughani Usha, Saha Arindam, Kuriakose Anshu, Nair Reshmi, Sadashivarao Ravindra B, Venkataraman Rasika, Patel Swati, Deshchougule Anuja Tushar, S Satish Kumar, Montero Enrique, Pai Harish V, Palanivelu Dinesh V, Melarkode Ramakrishnan and Nair Pradip. 20171006. T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab. : PloS one.

Harvard

Bughani U., Saha A., Kuriakose A., Nair R., Sadashivarao R. B., Venkataraman R., Patel S., Deshchougule A. T., S S. K., Montero E., Pai H. V., Palanivelu D. V., Melarkode R. and Nair P. (20171006). T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab. : PloS one.

MLA

Bughani Usha, Saha Arindam, Kuriakose Anshu, Nair Reshmi, Sadashivarao Ravindra B, Venkataraman Rasika, Patel Swati, Deshchougule Anuja Tushar, S Satish Kumar, Montero Enrique, Pai Harish V, Palanivelu Dinesh V, Melarkode Ramakrishnan and Nair Pradip. T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab. : PloS one. 20171006.